 Home > Active Ingredient News > Immunology News > ARD: Survival rates of French hospitalized patients with systemic lupus erythematosus after COVID-19-related organ failure: a national study

ARD: Survival rates of French hospitalized patients with systemic lupus erythematosus after COVID-19-related organ failure: a national study

 Last Update: 2021-12-27
 Source: Internet
 Author: User

Tags

3 2 simplified

gf 9 results

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Objective: Many SLE patients with immune suppression drugs, making it easier to infect virus and often suffer from chronic kidney or heart vascular disease, which is a serious COVID-19 additional risk factors
.

On the other hand, glucocorticoids and hydroxychloroquine are the most widely used drugs for the treatment of SLE and have also been studied for the treatment of COVID-19

Objective: Many SLE patients with immune suppression drugs, making it easier to infect virus and often suffer from chronic kidney or heart vascular disease, which is a serious immune infected vascular COVID-19 COVID-19 additional risk factors

Methods: The researchers used the French national medical / administrative hospital database in 2011 Nian 1 month to 2020 Nian 11 were cohort study during the month
.

In 2020 Nian 11 prior months in French hospital diagnosis is COVID-19-AOF of each SLE patients and five with COVID-19-AOF Africa SLE random match the patient

Methods: The researchers used the French national medical / administrative hospital database in 2011 Nian 1 month to 2020 Nian 11 were cohort study during the month

Results: 2020 Nian 3 months to 11 months, France has 127,380 hospitalizations in line with COVID-19-AOF defined above, wherein 196 times consistent with a diagnosis of SLE patients

Conclusion: COVID-19-AOF is related to the delayed prognosis of SLE patients

Source:

Mageau A, Papo T, Ruckly S , et al .

Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
Annals of the Rheumatic DiseasesPublished Online First: 10 December 2021.

Mageau A, Papo T, Ruckly S , et al .
Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study.
Annals of the Rheumatic DiseasesPublished Online First: 10 December 2021.
doi: 10.
1136 /annrheumdis-2021-221599 , et al Annals of the Rheumatic Diseases leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.